PreCharge: Digital Program for People Affected by Hereditary Cancer

About the Study

PreCharge is an IRB approved, nationwide study funded by the National Cancer Institute. The purpose of this study is to test a digital program designed to help people affected by hereditary cancer and who have not been diagnosed with cancer improve their mental and emotional well-being. 

Visit prochange.com/precharge to learn more about the PreCharge study and sign up.

What the Study Involves

The PreCharge study is a pilot study designed to test a digital program which provides support and tools—through text messages and online activities—to assist people affected by hereditary cancer and who have not been diagnosed with cancer take charge of their health and improve their mental and emotional well-being.

Those interested in participating in the study will be asked to complete a brief screening assessment to see if they are eligible. Eligible participants will be asked to:

• Complete a more in-depth online survey that will take 10 minutes to complete.
• Receive daily, personalized text messages for 1 month.
• Complete as many online activities as they would like for 1 month.
• Complete a final survey after 1 month of receiving text messages and using the online program. In that survey, participants will provide feedback on the daily messages and activities. The survey will take about 10 minutes to complete.

People who have an inherited mutation in one of these genes are eligible: APC, ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CDK4, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53

Eligible participants who complete the surveys will be paid for their time.

Visit prochange.com/precharge to learn more about the PreCharge study and to find instructions on how to sign up.

Lead Researchers

PI: Kerry E. Evers, Ph.D.
Co-President and CEO of ProChange Behavior Solutions